Revenue: The sum of all revenue fields included for a company's operating activities.
Bionano Genomics, Inc. (BNGO) had Revenue of $7.95M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$7.95M |
$-7.93M |
|
$4.55M |
|
$3.40M |
|
$16.49M |
|
$-8.54M |
|
$0.64M |
|
$-7.90M |
|
$-7.90M |
|
$-7.93M |
|
$-7.93M |
|
$-7.93M |
|
$-7.93M |
|
$-8.54M |
|
$-6.40M |
|
5.45M |
|
5.45M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$45.39M |
|
$14.85M |
|
$28.20M |
|
$73.58M |
|
$22.94M |
|
$3.48M |
|
$6.22M |
|
$29.16M |
|
$44.42M |
|
$40.08M |
|
$44.42M |
|
10.74M |
|
| Cash Flow Statement Financials | |
$-16.34M |
|
$-12.75M |
|
$24.04M |
|
$9.57M |
|
$4.51M |
|
$-5.06M |
|
$4.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
0.07 |
|
0.31 |
|
42.76% |
|
-107.36% |
|
-107.36% |
|
-- |
|
-99.32% |
|
-99.77% |
|
$-16.34M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
0.84 |
|
1.53 |
|
58.86 |
|
-17.86% |
|
-19.79% |
|
-10.78% |
|
-16.56% |
|
$4.14 |
|
$-3.00 |
|
$-3.00 |
|